Medical Information
United States
 

In order to provide you with relevant and meaningful content we need to know more about you.

Please choose the category that best describes you.

Información selecta para pacientes y cuidadores que se encuentra disponible en Español.

This content is intended for U.S. Healthcare Professionals. Would you like to proceed?

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.
Not a healthcare professional? Go to the patient or caregiver website.

CABERGOLINE Tablets (GREENSTONE LLC)

If you provide additional keywords, you may be able to browse through our database of Scientific Response Documents.

Our scientific content is evidence-based, scientifically balanced and non-promotional. It undergoes rigorous internal medical review and is updated regularly to reflect new information.

CABERGOLINE Tablets (GREENSTONE LLC) Quick Finder

INDICATIONS AND USAGE

Cabergoline tablets are indicated for the treatment of hyperprolactinemic disorders, either idiopathic or due to pituitary adenomas.

Did you find an answer to your question? Yes No

DOSAGE AND ADMINISTRATION

The recommended dosage of cabergoline tablets for initiation of therapy is 0.25 mg twice a week. Dosage may be increased by 0.25 mg twice weekly up to a dosage of 1 mg twice a week according to the...

Did you find an answer to your question? Yes No

CONTRAINDICATIONS

Cabergoline tablets are contraindicated in patients with

  • Uncontrolled hypertension or known hypersensitivity to ergot derivatives.
  • History of cardiac valvular disorders, as...
Did you find an answer to your question? Yes No

WARNINGS

1. Pregnancy

Dopamine agonists in general should not be used in patients with pregnancy-induced hypertension, for example, preeclampsia, eclampsia, and post...

Did you find an answer to your question? Yes No

ADVERSE REACTIONS

The safety of cabergoline tablets has been evaluated in more than 900 patients with hyperprolactinemic disorders. Most adverse events were mild or moderate in severity.

In a 4-week, double-blind,...

Did you find an answer to your question? Yes No

OVERDOSAGE

Overdosage might be expected to produce nasal congestion, syncope, or hallucinations. Measures to support blood pressure should be taken if necessary.

Did you find an answer to your question? Yes No

DESCRIPTION

CABERGOLINE tablets contain cabergoline, a dopamine receptor agonist. The chemical name for cabergoline is 1-[(6-allylergolin-8β-yl)-carbonyl]-1-[3-(dimethylamino) propyl]-3-ethylurea. Its empirical formula is C...

Did you find an answer to your question? Yes No

CLINICAL PHARMACOLOGY

Mechanism of Action

The secretion of prolactin by the anterior pituitary is mainly under hypothalamic inhibitory control, likely exerted through...

Did you find an answer to your question? Yes No

HOW SUPPLIED

Cabergoline tablets are white, scored, oblong tablets containing 0.5 mg cabergoline. Each tablet is scored on one side and has the letter P and the letter U on either side of the breakline. The other side of the...

Did you find an answer to your question? Yes No

Rx only

This product's label may have been updated. For current full prescribing information, please visit www.Greenstonellc.com

...

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No
Didn’t find what you were looking for? Contact us.
Report Adverse Event